Venkat Nelabhotla
-
Vyome Seals Strategic Pact With Impetis Biosciences, Unlocking a ~$57 Billion Market Horizon
83 0Vyome Partners With Impetis, a TATA Enterprise, to In‑License Next‑Generation…
Read more -
Vyome Delivers Breakthrough 2025 Performance, Sets Stage for Next Growth Chapter
73 0Vyome is building the world’s premier platform spanning the US-India…
Read more

